Arrhythmogenic Right Ventricular Dysplasia Clinical Trials
5 recruiting trials for Arrhythmogenic Right Ventricular Dysplasia. Eligibility criteria explained in plain English.
TrialFinderData lists 5 Arrhythmogenic Right Ventricular Dysplasia clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Universitätsklinikum Hamburg-Eppendorf (1), University Hospital, Toulouse (1), St. George's Hospital, London (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Peripheral immunological assessment on venous blood (biological, 1 trial), followed by Immunological assessment carried out on intracardiac material, obtaining a buccal smear sample.
Track Arrhythmogenic Right Ventricular Dysplasia trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Clinical Cohort Study - TRUST
The "Long-term Outcome and Predictors for Recurrence after Medical and Interventional Treatment of Arrhythmias at the University Heart Center Hamburg" (TRUST) study is an...
Local Inflammation in Arrhythmogenic Right Ventricular Cardiomyopathy
The understanding of ARVC pathophysiology remains incomplete. Several clues indicate that disease progression is mediated through inflammation. The present study aim to document...
Distribution of Cell-cell Junction Proteins in Arrhythmic Disorders
Every week in the UK, 12 apparently healthy and fit individuals under the age of 35 die suddenly, a tragic event known as sudden cardiac death (SCD). The investigators have shown...
Mayo AVC Registry and Biobank
Arrhythmogenic ventricular cardiomyopathy (AVC) is a genetic condition which affects the heart and can lead to heart failure and rhythm problems, of which, sudden cardiac arrest...
National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's...
The goal of this observational study is to develop a registry of Brazilian patients with hereditary cardiovascular diseases, combining clinical and genomic data. The main...
Explore Other Conditions
Frequently Asked Questions
There are currently 5 clinical trials for Arrhythmogenic Right Ventricular Dysplasia, with 5 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Arrhythmogenic Right Ventricular Dysplasia, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Arrhythmogenic Right Ventricular Dysplasia, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.